SCHEMBL7974542

SCHEMBL7974542

CNc1cccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)c1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 2/20 0.52
KMT2A Q03164 2/20 0.49
GAA P10253 1/20 0.43
PARN O95453 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
BRD4 O60885 2/20 0.40
PNP P00491 1/20 0.39
ADORA3 P0DMS8 2/20 0.38
ADORA2B P29275 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
XBP1 P17861 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CXCR2 P25025 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984466 0.89 HPGD (0.42) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7974456 0.89 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7988590 0.86 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7975265 0.86 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7984655 0.85 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7974010 0.85 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7974551 0.84 CNOT7 (0.47) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
Hydrochloric Acid SCHEMBL7987658 0.84 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7987251 0.84 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7985332 0.84 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed